This study was designed to assess the bioavailability and bioequivalence between a generic formulation of lamotrigine (test product) and the reference product LAMICTAL ® , after oral administration of a single-dose. Subjects and Methods Study productsTest product, LAMOTRIGINE 100 mg immediate release tablets, was a mixture of the lots LP1607, LP1707 and LP1807 made on an equal number of tablets of each batch.The product was manufactured